DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution
Showing posts with label N-4-Dimethyl-N-[(trifluoromethyl)sulfanyl]benzene-1-sulfonamide. Show all posts
Showing posts with label N-4-Dimethyl-N-[(trifluoromethyl)sulfanyl]benzene-1-sulfonamide. Show all posts

Wednesday, 20 April 2016

N-4-Dimethyl-N-[(trifluoromethyl)sulfanyl]benzene-1-sulfonamide

N-4-Dimethyl-N-[(trifluoromethyl)sulfanyl]benzene-1-sulfonamide

purified by flash chromatography (cyclohexane/ethyl acetate: 99:1 to 96:4) to afford BB23 (84.22 g, 88%, light yellow solid).
1H NMR (400 MHz, CDCl3) δ = 7.75 (m, 2H), 7.35 (m, 2H), 3.31 (s, 3H), 2.44 (s, 3H).
13C NMR (101 MHz, CDCl3) δ = 145.1, 134.3, 130.1, 129.0 (q, 3J(C,F) = 316 Hz), 127.9, 43.8, 21.7.
19F NMR (376 MHz, CDCl3) δ = −50.34 (s, 3F).

STR1
STR1
STR1
////////



 .


 

 


 

 
 

 

 
 

 
 
 

 
 
//////